# Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma

> **NCT00469469** · PHASE2 · WITHDRAWN · sponsor: **Dartmouth-Hitchcock Medical Center**

## Conditions studied

- Adrenocortical Carcinoma

## Interventions

- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT00469469
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-05
- **Primary completion:** —
- **Final completion:** 2009-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** unable to enroll subjects into the study
- **Last updated:** 2015-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00469469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00469469, "Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00469469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*